Figure 3From: Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon Clinical progression by infection group: progression to death (A), and progression to death or new AIDS-defining event (B).Back to article page